Central Garden & Pet Company CENT
39.51
0.00
0.00%
as of 25 Sep
- Market cap
- $2.2B
- P/E
- 14.6×
Follow CENT
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
16.42 | 13.27 | 13.02 | 12.66 |
+8 more quarters Free account |
P/S ratio |
0.88 | 0.71 | 0.64 | 0.66 | |
P/FCF ratio |
7.88 | 7.99 | 6.93 | 7.08 | |
P/Operating CF |
8.32 | (45.47) | (28.12) | 11.27 | |
P/B ratio |
1.56 | 1.37 | 1.25 | 1.30 | |
Price to Tangible BV |
3.52 | 3.41 | 3.40 | 3.54 | |
EV/Sales |
0.94 | 0.88 | 0.79 | 0.75 | |
EV/EBITDA |
8.67 | 8.02 | 7.45 | 6.95 | |
EV/Operating CF |
7.44 | 8.47 | 7.34 | 7.08 | |
EV/FCF |
8.41 | 9.84 | 8.52 | 8.08 | |
Quick Ratio |
2.61 | 2.10 | 1.91 | 2.27 | |
Current Ratio |
3.79 | 3.45 | 3.42 | 3.67 | |
Net Debt/EBITDA |
1.24 | 3.87 | 12.03 | 18.19 | |
Debt/Assets |
31.48% | 31.84% | 32.72% | 32.87% | |
Debt/Equity |
0.68 | 0.72 | 0.76 | 0.75 | |
Asset Turnover |
0.83 | 0.86 | 0.86 | 0.87 | |
Operating CF/Net income |
3.64 | (0.62) | (10.26) | (18.63) | |
Capex/Depreciation |
(0.62) | (0.49) | (0.51) | (0.48) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
21.65% | 20.49% | 28.20% | 29.92% | |
Intangible Assets out of Total Assets |
0.26 | 0.26 | 0.27 | 0.28 | |
Share Based Compensation of Revenue |
0.71% | 0.51% | 0.78% | 0.81% | |
Graham Net Nets |
0.03 | 0.00 | (0.05) | (0.03) | |
Graham Number |
41.56 | 40.96 | 37.77 | 38.19 | |
Earnings Yield |
6.09% | 7.53% | 7.68% | 7.90% | |
Free Cash Flow Yield |
12.68% | 12.51% | 14.43% | 14.13% | |
Revenue per Share |
14.36 | 14.76 | 10.05 | 10.75 | |
Operating CF per Share |
5.33 | (0.81) | (1.14) | 2.90 | |
Capex per Share |
(0.20) | (0.17) | (0.18) | (0.17) | |
Free Cash Flow per Share |
5.12 | (0.98) | (1.32) | 2.72 | |
Cash per Share |
16.47 | 10.91 | 12.01 | 14.24 | |
Shareholders Equity per Share |
28.43 | 26.92 | 25.66 | 25.12 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
28.43 | 26.92 | 25.66 | 25.12 | |
Free Cash Flow |
314.87 | (60.09) | (81.03) | 171.89 | |
Working Capital |
1,570.99 | 1,482.56 | 1,391.70 | 1,437.37 | |
Capital Expenditures |
(12.59) | (10.45) | (10.81) | (10.84) | |
Net Current Asset Value |
91.65 | (5.46) | (101.77) | (64.58) | |
EV/EBIT |
11.63 | 10.73 | 10.18 | 9.41 | |
Capex to Sales |
0.01 | 0.01 | 0.02 | 0.02 | |
Net Profit Margin |
10.18% | 8.76% | 1.11% | (1.45%) | |
Price to Operating Income |
10.90 | 8.71 | 8.28 | 8.24 | |
| Other line items | |||||
Average Receivables |
491.48 | 591.02 | 378.62 | 325.76 | |
Average Payables |
214.10 | 270.06 | 242.75 | 223.61 | |
Average Inventory |
674.96 | 803.31 | 826.03 | 740.02 | |
Average Assets |
3,723.64 | 3,687.57 | 3,589.64 | 3,589.54 | |
Average Common Equity |
1,668.72 | 1,597.87 | 1,547.90 | 1,571.24 |
Columns are period end dates